Curis Lifesciences Ltd CURIS
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ₹206.50
- Day Range
- ₹207.00–208.00
- 52-Week Range
- ₹83.60–234.75
- Bid/Ask
- ₹207.00 / ₹212.00
- Shares Outstanding
- 8.08M
- Market Cap
- ₹1.68B
- Volume/Avg
- 5,000 / 13,880
Key Statistics
- Price/Earnings (Normalized)
- 5.56
- Price/Sales
- 0.64
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Curis Lifesciences Ltd is engaged in the development, manufacturing, and distribution of pharmaceutical products catering to various therapeutic categories and healthcare requirements. The Company manufactures pharmaceutical formulations mainly comprising tablets, capsules, oral liquids, external preparations such as creams, gels and ointments, and sterile ophthalmic ointments. Its business model includes manufacturing pharmaceutical products for domestic and international markets through loan licensing, contract manufacturing and own-brand marketing arrangements. The Company operates through a single segment, namely manufacturing of pharmaceutical products.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 86
- Website
- https://www.curisls.com
Valuation
|
Metric
|
CURIS
|
|---|---|
Price/Earnings (Normalized) | 5.56 |
Price/Book Value | 3.53 |
Price/Sales | 0.64 |
Price/Cash Flow | 4.94 |
Price/Earnings
CURIS
Financial Strength
|
Metric
|
CURIS
|
|---|---|
Quick Ratio | 1.04 |
Current Ratio | 2.52 |
Interest Coverage | 9.18 |
Quick Ratio
CURIS
Profitability
|
Metric
|
CURIS
|
|---|---|
Return on Assets (Normalized) | 11.29% |
Return on Equity (Normalized) | 21.93% |
Return on Invested Capital (Normalized) | 15.13% |
Return on Assets
CURIS
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|!ZN$Yvnf | LOCK|$jg% | $67B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|fN@#&yJW | LOCK|PlF^V | $46B | |||
| Haleon PLC ADR
HLN
| LOCK|f&cDhn | LOCK|RB | $38B | |||
| Zoetis Inc Class A
ZTS
| LOCK|R&!Gcqk | LOCK|HJm | $29B | |||
| Viatris Inc
VTRS
| LOCK|DXlYJ<Y | LOCK|<% | $20B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|<M | LOCK|&bG | $11B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|%PDnk< | LOCK|Pp | $10B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|>$F<p? | LOCK|P$K | $7B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|g&f^>@D | LOCK|b%?# | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|dWhCw^ | LOCK|nqD | $2B |
United States